Classification of myeloid neoplasms: A comparative review

Veterinary Clinical Pathology

Volumn 34, Issue 3, 2005, Pages 189-212

  McManus, Patricia M ^a,b   Monteith, C N ^c   Cole, D ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Veterinary Diagnostic Imaging and Cytopathology   (United States)

^c NONE

Author keywords

AML; Classification; Myelodysplastic syndromes; Myeloid leukemia; Myeloproliferative disorders

Indexed keywords

EID: 26244439893     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2005.tb00042.x     Document Type: Review

References (139)

1. Jain NC, Blue JT, Grindem CB, et al. Proposed criteria for classification of acute myeloid leukemia in dogs and cats. Vet Clin Pathol. 1991; 20:63-82.
2. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med. 1985; 103:460-162.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985; 103:620-625.
4. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33:451-458.
5. Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813-819.
6. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
7. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292-2302.
8. Lichtman MA. Language and the clonal myeloid diseases. Blood. 2002;99:725-726.
9. Lichtman MA. Myelodysplasia or myeloneoplasia: thoughts on the nosology of clonal myeloid diseases. Blood Cells Mol Dis. 2000;26: 572-581.
10. Georgii A, Buesche G, Kreft A. The histopathology of chronic myeloproliferative diseases. Baillieres Clin Haematol. 1998;11:721-749.
11. Bennett JM, Brunning RD, Vardiman JW. Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary. Blood. 2002;99:3074-3075.
12. Kuriyama K, Tomonaga M, Matsuo T, Ginnai I, Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micro-megakaryocytes in myelodysplastic syndrome. Br J Haematol. 1986;63:665-669.
13. Ramos F, Fernandez-Ferrero S, Suarez D, et al. Myelodysplastic syndrome: a search for minimal diagnostic criteria. Leuk Res. 1999; 23:283-290.
14. Arber DA, Stein AS, Carter NH, et al. Prognostic impact of acute myeloid leukemia classification: importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. Am J Clin Pathol. 2003;119:672-680.
15. Meckenstock G, Aul C, Hildebrandt B, et al. Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance. Leuk Lymphoma. 1998;29:523-531.
16. Winton EF, Langston AA. Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukemia in adults. Semin Oncol. 2004;31:80-86.
17. Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C. Genetic classification of acute myeloid leukemia (AML). Ann Hematol. 2004; 83 Suppl 1:S97-100.
18. Lo Coco F, Pelicci PG, Biondi A. Clinical relevance of the PML-RARα gene rearrangement in acute promyelocytic leukaemia. Leuk Lymphoma. 1994;12:327-332.
19. Lichtman MA. Differentiation versus maturation of neoplastic hematopoietic cells: an important distinction. Blood Cells Mol Dis. 2001;27:649-652.
20. Puccetti E, Ruthardt M. Acute promyelocytic leukemia: PML-RARα and the leukemic stem cell. Leukemia. 2004;18:1169-1175.
21. Lo Coco F, Nervi C, Avvisati G, Mandelli F. Acute promyelocytic leukemia: a curable disease. Leukemia. 1998;12:1866-1880.
22. Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukaemia with recurrent genetic abnormalities. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:81-87.
23. Löwenberg B, Griffin JD, Tallman MS. Acute myeloid leukemia and acute promyelocytic leukemia. Hematology (Am Soc Hematol Educ Program). 2003:82-101.
24. Miller KB, Daoust PR. Clinical manifestations of acute myeloid leukemias. In: Hoffman R, Benz EJ, Shattil SJ, et al., eds. Hematology: Basic Principles and Practice. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2000:999-1024.
25. Brunning RD, Matutes E, Harris NL, et al. Acute myeloid leukaemia with multilineage dysplasia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:88-89.
26. Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. The incidence of secondary leukemias. Haematologica. 1999;84:937-945.
27. Dann EJ, Rowe JM. Biology and therapy of secondary leukaemias. Best Pract Res Clin Haematol. 2001;14:119-137.
28. Pedersen-Bjergaard J, Philip P. Two different classes of therapy-related and de-novo acute myeloid leukemia? Cancer Genet Cytogenet. 1991;55:119-124.
29. Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukaemias and myelodysplastic syndromes, therapy related. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:89-91.
30. Karp JE, Sarkodee-Adoo CB. Therapy-related acute leukemia. Clin Lab Med. 2000;20:71-81, ix.
31. Tallman MS. Relevance of pathologic classifications and diagnosis of acute myeloid leukemia to clinical trials and clinical practice. Cancer Treat Res. 2004;121:45-67.
32. Court EL, Smith MA, Avent ND, et al. DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines. Leuk Res. 2004;28:743-753.
33. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350: 1617-1628.
34. Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood. 2004;104:923-932.
35. Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukaemia not otherwise categorised. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:91-105.
36. Kaleem Z, White G. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal. Am J Clin Pathol. 2001;115:876-884.
37. Odom LF, Lampkin BC, Tannous R, Buckley JD, Hammond GD. Acute monoblastic leukemia: a unique subtype - a review from the Children's Cancer Study Group. Leuk Res. 1990;14:1-10.
38. Tobelem G, Jacquillat C, Chastang C, et al. Acute monoblastic leukemia: a clinical and biologic study of 74 cases. Blood. 1980;55: 71-76.
39. Fung H, Shepherd JD, Naiman SC, et al. Acute monocytic leukemia: a single institution experience. Leuk Lymphoma. 1995;19:259-265.
40. Goasguen JE, Bennett JM. Classifications of acute myeloid leukemia. Clin Lab Med. 1990;10:661-681.
41. Tallman MS, Kim HT, Paietta E, et al. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group. J Clin Oncol. 2004;22:1276-1286.
42. Goldberg SL, Noel P, Klumpp TR, Dewald GW. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease. Am J Clin Oncol. 1998;21:42-47.
43. Park S, Picard F, Azgui Z, et al. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification. Leuk Res. 2002;26:423-429.
44. Kowal-Vern A, Cotelingam J, Schumacher HR. The prognostic significance of proerythroblasts in acute erythroleukemia. Am J Clin Pathol. 1992;98:34-40.
45. Hasserjian RP, Howard J, Wood A, Henry K, Bain B. Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6. J Clin Pathol. 2001;54:205-209.
46. Soondergaard-Petersen H. The Di Guglielmo syndrome: a study of 17 cases - I, clinical and haematological manifestations. Acta Med Scand. 1975;198:165-174.
47. Park S, Picard F, Dreyfus F. Erythroleukemia: a need for a new definition. Leukemia. 2002;16:1399-1401.
48. Zini G, d'Onofrio G. Epitaph for erythroleukemia. Haematologica. 2004;89:ELT11.
49. Domingo-Claros A, Larriba I, Rozman M, et al. Acute erythroid neoplastic proliferations: a biological study based on 62 patients. Haematologica. 2002;87:148-153.
50. Duchayne E, Fenneteau O, Pages MP, et al. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Francais d'Hematologie Cellulaire (GFHC). Leuk Lymphoma. 2003;44:49-58.
51. Tallman MS, Neuberg D, Bennett JM, et al. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood. 2000;96:2405-2411.
52. Thiele J, Kvasnicka HM, Schmitt-Graeff A. Acute panmyelosis with myelofibrosis. Leuk Lymphoma. 2004;45:681-687.
53. Thiele J, Kvasnicka HM, Zerhusen G, et al. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Ann Hematol. 2004;83:513-521.
54. Brunning RD, Matutes E, Borowitz M, et al. Acute myeloid leukaemias of ambiguous lineage. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:106-107.
55. Evans RJ, Gorman NT. Myeloproliferative disease in the dog and cat: definition, aetiology and classification. Vet Rec. 1987;121:437-443.
56. Young KM. Myeloproliferative disorders. Vet Clin North Am Small Anim Pract. 1985;15:769-781.
57. George TI, Arber DA. Pathology of the myeloproliferative diseases. Hematol Oncol Clin North Am. 2003;17:1101-1127.
58. Prchal JT. Classification and molecular biology of polycythemias (erythrocytoses) and thrombocytosis. Hematol Oncol Clin North Am. 2003;17:1151-1158, vi.
59. Bain BJ. Overview. Cytogenetic analysis in haematology. Best Pract Res Clin Haematol. 2001;14:463-477.
60. Xu Y, Dolan MM, Nguyen PL. Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemia. Am J Clin Pathol. 2003;120:778-784.
61. Hasford J, Pfirrmann M, Hehlmann R, et al. Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy. Semin Hematol. 2003;40:4-12.
62. Thomas MJ, Irving JA, Lennard AL, Proctor SJ, Taylor PR. Validation of the Hasford score in a demographic study in chronic granulocytic leukaemia. J Clin Pathol. 2001;54:491-493.
63. Hasford J, Pfirrmann M, Hehlmann R, et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst. 1998;90:850-858.
64. Kvasnicka HM, Thiele J, Schmitt-Graeff A, et al. Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia - a multicentre study on 495 patients. Br J Haematol. 2001;112:727-739.
65. Imbert M, Bain B, Pierre R, et al. Chronic neutrophilic leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:27-28.
66. Bohm J, Schaefer HE. Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease. J Clin Pathol. 2002;55:862-864.
67. Reilly JT. Chronic neutrophilic leukaemia: a distinct clinical entity? Br J Haematol. 2002;116:10-18.
68. Hara K, Abe Y, Hirase N, et al. Apoptosis resistance of mature neutrophils in a case of chronic neutrophilic leukaemia. Eur J Haematol 2001;66:70-71.
69. Bohm J, Kock S, Schaefer HE, Fisch P. Evidence of clonality in chronic neutrophilic leukaemia. J Clin Pathol. 2003;56:292-295.
70. Froberg MK, Brunning RD, Dorion P, Litz CE, Torlakovic E. Demonstration of clonality in neutrophils using FISH in a case of chronic neutrophilic leukemia. Leukemia. 1998;12:623-626.
71. Grogan TM. Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features. Semin Diagn Pathol. 2003;20:211-225.
72. Standen GR, Steers FJ, Jones L. Clonality of chronic neutrophilic leukaemia associated with myeloma: analysis using the X-linked probe M27 beta. J Clin Pathol. 1993;46:297-298.
73. Kusaba N, Yoshida H, Ohkubo F, et al. Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia [in Japanese]. Rinsho Ketsueki. 2004;45:228-232.
74. Brito-Babapulle F. Clonal eosinophilic disorders and the hypereosinophilic syndrome. Blood Rev. 1997;11:129-145.
75. Bain B, Pierre R, Imbert M, et al. Chronic eosinophilic leukaemia and the hypereosinophilic syndrome. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:29-31.
76. Bauermeister DE. Quantitation of bone marrow reticulin-a normal range. Am J Clin Pathol. 1971;56:24-31.
77. Brito-Babapulle F. The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol. 2003;121:203-223.
78. Tefferi A. Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clin Proc. 2003;78:174-194.
79. Pierre R, Imbert M, Thiele J, et al. Polycythaemia vera. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:32-34.
80. Thiele J, Kvasnicka HM, Fischer R. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification. Ann Hematol. 1999;78:495-506.
81. Kiladjian JJ, Gardin C, Renoux M, Bruno F, Bernard JF. Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy. Hematol J. 2003;4:198-207.
82. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.
83. Buhr T, Busche G, Choritz H, Langer F, Kreipe H. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol. 2003;119:152-158.
84. Thiele J, Kvasnicka HM, Zankovich R, Diehl V. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Ann Hematol. 2001;80:160-165.
85. Dingli D, Mesa RA, Tefferi A. Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment. Intern Med. 2004;43:540-547.
86. Thiele J, Pierre R, Imbert M, et al. Chronic idiopathic myelofibrosis. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:35-38.
87. Imbert M, Pierre R, Thiele J, et al. Essential thrombocythaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:39-41.
88. Thiele J, Kvasnicka HM, Zankovich R, Diehl V. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. Haematologica. 2000;85:1126-1134.
89. Harrison CN. Current trends in essential thrombocythaemia. Br J Haematol. 2002;117:796-808.
90. Thiele J, Imbert M, Pierre R, et al. Chronic myeloproliferative disease, unclassifiable. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:42-44.
91. Aul C, Bowen DT, Yoshida Y. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica. 1998;83:71-86.
92. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
93. Tricot G, De Wolf-Peeters C, Hendrickx B, Verwilghen RL. Bone marrow histology in myelodysplastic syndromes: I, histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol. 1984;57:423-430.
94. Tricot G, De Wolf-Peeters C, Vlietinck R, Verwilghen RL. Bone marrow histology in myelodysplastic syndromes: II, prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol. 1984;58:217-225.
95. Verburgh E, Achten R, Maes B, et al. Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes. J Clin Oncol. 2003;21:273-282.
96. Bellamy WT, Richter L, Sirjani D, et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood. 2001;97:1427-1434.
97. Bennett JM. The myelodysplastic/myeloproliferative disorders: the interface. Hematol Oncol Clin North Am. 2003;17:1095-1100, v.
98. Onida F, Kantarjian HM, Smith TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002;99:840-849.
99. Vardiman JW, Pierre R, Bain B, et al. Chronic myelomonocytic leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:49-52.
100. Germing U, Gattermann N, Minning H, Heyll A, Aul C. Problems in the classification of CMML - dysplastic versus proliferative type. Leuk Res. 1998;22:871-878.
101. Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol. 1994;87:746-754.
102. Vardiman JW, Imbert M, Pierre R, et al. Atypical chronic myeloid leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:53-54.
103. Kurzrock R, Bueso-Ramos CE, Kantarjian H, et al. BCR rearrangement- negative chronic myelogenous leukemia revisited. J Clin Oncol. 2001;19:2915-2926.
104. Aurich J, Duchayne E, Huguet-Rigal F, et al. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias. Hematol Cell Ther. 1998;40:149-158.
105. Vardiman JW, Pierre R, Imbert M, et al. Juvenile myelomonocytic leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:55-57.
106. Woods WG, Barnard DR, Alonzo TA, et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin Oncol. 2002;20:434-440.
107. Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999;93:459-466.
108. Breuer W, Heinritzi K, Hermanns W. Akute myeloische Leukose (Promyelozyten-Leukose) mit Nachweis von Viruspartikeln bei einem Eber. Histologische, histochemische und ultrastrukturelle Befunde [Acute myeloid leukemia (promyelocytic leukemia) with detection of virus particles in a boar: histologic, histochemical and ultrastructural findings]. Berl Munch Tierarztl Wochenschr. 1995;108:380-384.
109. Kogan SC. Acute promyelocytic leukemia: a view from a mouse. Blood Cells Mol Dis. 2000;26:620-625.
110. Mazzella FM, Kowal-Vern A, Shrit MA, et al. Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am J Clin Pathol. 1998;110: 590-598.
111. Mazzella FM, Alvares C, Kowal-Vern A, Schumacher HR. The acute erythroleukemias. Clin Lab Med. 2000;20:119-137.
112. Jain NC. Classification of myeloproliferative disorders using criteria proposed by the Animal Leukaemia Study Group: a retrospective study of 181 cases (1969-1992). Comp Haematol Int. 1993;3:125-134.
113. Cain GR, Kawakami TG, Jain NC. Radiation-induced megakaryoblastic leukemia in a dog. Vet Pathol. 1985;22:641-643.
114. Shull RM, DeNovo RC, McCracken MD. Megakaryoblastic leukemia in a dog. Vet Pathol. 1986;23:533-536.
115. Cain GR, Feldman BF, Kawakami TG, Jain NC. Platelet dysplasia associated with megakaryoblastic leukemia in a dog. J Am Vet Med Assoc. 1986;188:529-530.
116. Messick J, Carothers M, Wellman M. Identification and characterization of megakaryoblasts in acute megakaryoblastic leukemia in a dog. Vet Pathol. 1990;27:212-214.
117. Colbatzky F, Hermanns W. Acute megakaryoblastic leukemia in one cat and two dogs. Vet Pathol. 1993;30:186-194.
118. Pucheu-Haston CM, Camus A, Taboada J, et al. Megakaryoblastic leukemia in a dog. J Am Vet Med Assoc. 1995;207:194-196.
119. Miyamoto T, Hachimura H, Amimoto A. A case of megakaryoblastic leukemia in a dog. J Vet Med Sci. 1996;58:177-179.
120. Burton S, Miller L, Horney B, Marks C, Shaw D. Acute megakaryoblastic leukemia in a cat. Vet Clin Pathol. 1996;25:6-9.
121. Hamilton TA, Morrison WB, DeNicola DB. Cytosine arabinoside chemotherapy for acute megakaryocytic leukemia in a cat. J Am Vet Med Assoc. 1991;199:359-361.
122. Grindem CB. Acute Myeloid Leukemia. In: Feldman BV, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000:717-726.
123. Valli VE, Jacobs RM, Parodi AL, Vernau W. Histological Classification of Hematopoietic Tumors of Domestic Animals. Vol VIII. Washington, DC: Armed Forces Institute of Pathology; 2002.
124. Couto CG. Clinicopathologic aspects of acute leukemias in the dog. J Am Vet Med Assoc. 1985;186:681-685.
125. Grindem CB, Stevens JB, Perman V. Morphological classification and clinical and pathological characteristics of spontaneous leukemia in 17 dogs. J Am Anim Hosp Assoc. 1985;21:219-226.
126. Blue JT, French TW, Kranz JS. Non-lymphoid hematopoietic neoplasia in cats: a retrospective study of 60 cases. Cornell Vet. 1988;78:21-12.
127. Latimer KS, Dykstra MJ. Acute monocytic leukemia in a dog. J Am Vet Med Assoc. 1984;184:852-854.
128. Antognoni MT, Mangili V, Spaterna A, Fruganti G. Acute myeloid leukaemia in five dogs: clinical findings and cytochemical characterization. Vet Res Commun. 2003;27(suppl 1):367-371.
129. Modiano JF, Smith R, 3rd, Wojcieszyn J, et al. The use of cytochemistry, immunophenotyping, flow cytometry, and in vitro differentiation to determine the ontogeny of a canine monoblastic leukemia. Vet Clin Pathol. 1998;27:40-49.
130. Graves TK, Swenson CL, Scott MA. A potentially misleading presentation and course of acute myelomonocytic leukemia in a dog. J Am Anim Hosp Assoc. 1997;33:37-41.
131. Clark P, Swenson CL, Drenen CM. A 6-year-old Rottweiler with weight loss. Aust Vet J. 1997;75:709,714-705.
132. Hamlin RH, Duncan RC. Acute nonlymphocytic leukemia in a dog. J Am Vet Med Assoc. 1990;196:110-112.
133. Christopher MM, Metz AL, Klausner J, Polzin D, Hayden DW. Acute myelomonocytic leukemia with neurologic manifestations in the dog. Vet Pathol. 1986;23:140-147.
134. Carpenter JL, King NW, Jr., Abrams KL. Bilateral trigeminal nerve paralysis and Horner's syndrome associated with myelomonocytic neoplasia in a dog. J Am Vet Med Assoc. 1987;191:1594-1596.
135. Keller P, Sager P, Freudiger U, Speck B. Acute myeloblastic leukaemia in a dog. J Comp Pathol. 1985;95:619-632.
136. Mears EA, Raskin RE, Legendre AM. Basophilic leukemia in a dog. J Vet Intern Med. 1997;11:92-94.
137. Clark P, Cornelisse CJ, Schott HC, Swenson CL, Bell TG. Myeloblastic leukaemia in a Morgan Horse mare. Equine Vet J. 1999;31:446-148.
138. Ringger NC, Edens L, Bain P, Raskin RE, Larock R. Acute myelogenous leukaemia in a mare. Aust Vet J. 1997;75:329-331.
139. Latimer KS, White SL. Acute monocytic leukaemia (M5a) in a horse. Comp Haematol Int. 1996;6:111-114.